NEUP Neuphoria: Market Valuation

Public company logo of Neuphoria (NEUP)

Neuphoria Therapeutics Inc. (NEUP) is actively developing a pipeline of non-benzodiazepine agents to combat PTSD and anxiety by 2026. Business prospects rely on the efficacy of BNC210 and the search for a commercial partner. This price chart, where the market capitalization is fixed at 0.01, illustrates a company creating safe, fast-acting small molecules for the therapy of depressive states.

NEUP Neuphoria Therapeutics, Inc.: Market Valuation in the range 12/25/2024 - 11/17/2026

NEUP (Neuphoria): analytical breakdowns and indicator data

- current price and projected stock value:
Fundamental company analysis:NEUP (Neuphoria Therapeutics)
Product sample of Neuphoria Therapeutics, Inc.

Long-term investing requires strict control over overpayment relative to the actual value of the business. For Neuphoria Therapeutics Inc. (NEUP), this is critical given the stringent FDA oversight and the duration of clinical trials. The issuer's total market capitalization is calculated as the product of the share price and the total number of shares. This metric determines the market price for a full buyout of the company. The trend of this indicator reflects market confidence in the developer's patents.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|VYGR - Market Capitalization|neumoratx.com (NMRA) - Market Value|Market Value Scilex Holding Company (SCLX)|TVGN (Tevogen Bio Holdings Inc.) - Market Capitalization|ACOG: Market Value|Market Capitalization CGTX|Market Capitalization Inhibikase Therapeutics Inc (IKT)|Cassava - Market Valuation|assertiotx.com (ASRT) - Market Value|COYA - Market Value|Market Value VTGN (VistaGen Therapeutics, Inc.)|OVID: Market Capitalization|Acumen Pharmaceuticals Inc. (ABOS) - Market Capitalization|Market Value CervoMed Inc.|ATHE: Market Value|Market Value Clene (CLNN)|PEPG: Market Valuation|Market Value Jupiter Neurosciences, Inc. JUNS|Market Capitalization Relmada Therapeutics Inc RLMD|ANVS - Market Value|GRCE - Market Capitalization|AIFF: Market Capitalization|KLTO - Market Capitalization|NRSN (NeuroSense Therapeutics, Ltd.) - Market Capitalization|Market Capitalization Reviva Pharmaceuticals Holdings|Market Capitalization MTVA|Market Capitalization NeurAxis Inc|Helius Medical Technologies - Market Valuation|Market Capitalization Passage Bio, Inc. PASG|Minerva Neurosciences Inc - Market Capitalization|ATHA - Market Capitalization|ADXN: Market Capitalization|Alzamend (ALZN) - Market Capitalization|CYCN (cyclerion.com) - Market Capitalization|Protagenic Therapeutics (PTIX) - Market Capitalization|Market Value pasitheaclinics.com (KTTA)|CRGT (Cortigent Inc) - Market Value|Market Capitalization ATXI (Avenue Therapeutics Inc)|Market Value BCLI|Cara Therapeutics Inc - Market Capitalization|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics